Jazz Pharmaceuticals plcJazz Pharmaceuticals plcJazz Pharmaceuticals plc

Jazz Pharmaceuticals plc

No trades
See on Supercharts

JAZZ fundamentals

Jazz Pharmaceuticals plc financial statements, including revenue, expenses, profit, and loss

The total revenue of JAZZ for the last quarter is 1.01 B USD, and it's 4.09% higher compared to the previous quarter. The net income of Q4 23 is 94.15 M USD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth